why choose us

First received: December 09, 2022

Clinical Trial: A Study of MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: End-Stage Renal Disease

Study Type: INTERVENTIONAL


Official Title: A Single-and Multiple Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Subcutaneous MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease

Brief Summary: This is a three-part study of MK-2060 in participants with chronic and/or end-stage kidney disease.The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single subcutaneous dose of MK-2060 in stage 4 chronic kidney disease (CKD4) or stage 5 chronic kidney disease (CKD5) participants in Part 1, of multiple subcutaneous doses in CKD4 or CKD5 participants in Part 2, and of a single subcutaneous dose of MK-2060 in participants with end-stage kidney disease in…

Read more